Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey

Overview of attention for article published in Frontiers in Cardiovascular Medicine, December 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 25,898 followers.

RT @SeguraCardio: 📂 https://t.co/ldHL5AXFuJ

14 Jan 2022

Reply Repost Favourite

RT @SeguraCardio: 📂 https://t.co/ldHL5AXFuJ

12 Jan 2022

Reply Repost Favourite

📂 https://t.co/ldHL5AXFuJ

11 Jan 2022

Reply Repost Favourite

New Research: Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey: Type 2 diabetes mellitus (T2DM) and heart failure (HF) are multifactorial diseases sharing common risk factors, such as obesity,… https://t.co/BlUMTB3a29

23 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.